Literature DB >> 33946436

Applying MRI Intensity Normalization on Non-Bone Tissues to Facilitate Pseudo-CT Synthesis from MRI.

Kuei-Yuan Hou1,2, Hao-Yuan Lu3, Ching-Ching Yang4,5.   

Abstract

This study aimed to facilitate pseudo-CT synthesis from MRI by normalizing MRI intensity of the same tissue type to a similar intensity level. MRI intensity normalization was conducted through dividing MRI by a shading map, which is a smoothed ratio image between MRI and a three-intensity mask. Regarding pseudo-CT synthesis from MRI, a conversion model based on a three-layer convolutional neural network was trained and validated. Before MRI intensity normalization, the mean value ± standard deviation of fat tissue in 0.35 T chest MRI was 297 ± 73 (coefficient of variation (CV) = 24.58%), which was 533 ± 91 (CV = 17.07%) in 1.5 T abdominal MRI. The corresponding results were 149 ± 32 (CV = 21.48%) and 148 ± 28 (CV = 18.92%) after intensity normalization. With regards to pseudo-CT synthesis from MRI, the differences in mean values between pseudo-CT and real CT were 3, 15, and 12 HU for soft tissue, fat, and lung/air in 0.35 T chest imaging, respectively, while the corresponding results were 3, 14, and 15 HU in 1.5 T abdominal imaging. Overall, the proposed workflow is reliable in pseudo-CT synthesis from MRI and is more practicable in clinical routine practice compared with deep learning methods, which demand a high level of resources for building a conversion model.

Entities:  

Keywords:  MRI intensity normalization; convolutional neural network; pseudo-CT synthesis

Year:  2021        PMID: 33946436     DOI: 10.3390/diagnostics11050816

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  21 in total

1.  T1/T2*-weighted MRI provides clinically relevant pseudo-CT density data for the pelvic bones in MRI-only based radiotherapy treatment planning.

Authors:  Mika Kapanen; Mikko Tenhunen
Journal:  Acta Oncol       Date:  2012-06-19       Impact factor: 4.089

Review 2.  A review of methods for correction of intensity inhomogeneity in MRI.

Authors:  Uros Vovk; Franjo Pernus; Bostjan Likar
Journal:  IEEE Trans Med Imaging       Date:  2007-03       Impact factor: 10.048

3.  Shading correction algorithm for improvement of cone-beam CT images in radiotherapy.

Authors:  T E Marchant; C J Moore; C G Rowbottom; R I MacKay; P C Williams
Journal:  Phys Med Biol       Date:  2008-09-26       Impact factor: 3.609

4.  Intensity correction in surface-coil MR imaging.

Authors:  L Axel; J Costantini; J Listerud
Journal:  AJR Am J Roentgenol       Date:  1987-02       Impact factor: 3.959

Review 5.  Review of potential improvements using MRI in the radiotherapy workflow.

Authors:  Alberto Torresin; Maria Grazia Brambilla; Angelo F Monti; Alessio Moscato; Marc A Brockmann; Lothar Schad; Ulrike I Attenberger; Frank Lohr
Journal:  Z Med Phys       Date:  2015-03-14       Impact factor: 4.820

Review 6.  Attenuation Correction of PET/MR Imaging.

Authors:  Yasheng Chen; Hongyu An
Journal:  Magn Reson Imaging Clin N Am       Date:  2017-01-18       Impact factor: 2.266

7.  Attenuation correction synthesis for hybrid PET-MR scanners: application to brain studies.

Authors:  Ninon Burgos; M Jorge Cardoso; Kris Thielemans; Marc Modat; Stefano Pedemonte; John Dickson; Anna Barnes; Rebekah Ahmed; Colin J Mahoney; Jonathan M Schott; John S Duncan; David Atkinson; Simon R Arridge; Brian F Hutton; Sebastien Ourselin
Journal:  IEEE Trans Med Imaging       Date:  2014-07-17       Impact factor: 10.048

Review 8.  A review of substitute CT generation for MRI-only radiation therapy.

Authors:  Jens M Edmund; Tufve Nyholm
Journal:  Radiat Oncol       Date:  2017-01-26       Impact factor: 3.481

9.  Radiotherapy planning using MRI.

Authors:  Maria A Schmidt; Geoffrey S Payne
Journal:  Phys Med Biol       Date:  2015-10-28       Impact factor: 3.609

10.  Generation of Pseudo-CT using High-Degree Polynomial Regression on Dual-Contrast Pelvic MRI Data.

Authors:  Samuel C Leu; Zhibin Huang; Ziwei Lin
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.